Prospective, multicenter, randomized controlled study on the efficacy and safety of intravascular ultrasound-guided drug-coated balloon for de novo small-vessel coronary lesions: Design and rationale of the DCB-IVUS trial

Jun 27, 2026 by in CARDIOLOGY Comments Off on Prospective, multicenter, randomized controlled study on the efficacy and safety of intravascular ultrasound-guided drug-coated balloon for de novo small-vessel coronary lesions: Design and rationale of the DCB-IVUS trial
Background The effectiveness and safety of drug-coated balloon (DCB) have been extensively studied in the treatment of de novo small-vessel coronary lesions. Proper lesion preparation is essential prior to performing…
read more

Towards an understanding of best practice: The good, the bad and the future of cardiogenic shock teams

Jun 27, 2026 by in CARDIOLOGY Comments Off on Towards an understanding of best practice: The good, the bad and the future of cardiogenic shock teams
ABSTRACT Cardiogenic shock (CS) remains a high-mortality condition that demands rapid diagnosis, coordinated multidisciplinary management, and timely initiation of mechanical circulatory support. As more institutions implement dedicated CS teams, substantial…
read more

Routine versus selective protamine administration to reduce bleeding after TAVI: Rationale and design of the POPular ACE TAVI trial

Jun 27, 2026 by in CARDIOLOGY Comments Off on Routine versus selective protamine administration to reduce bleeding after TAVI: Rationale and design of the POPular ACE TAVI trial
ABSTRACT Background Unfractionated heparin is routinely used during transcatheter aortic valve implantation (TAVI) to reduce catheter thrombosis and thromboembolism. Protamine reverses the effect of heparin and may lower bleeding risk,…
read more

Corrigendum to “Medical treatment of hypercortisolism with relacorilant: Final results of the phase 3 GRACE study” [American Heart Journal 278S (2024) Pages 10-11]

Jun 27, 2026 by in CARDIOLOGY Comments Off on Corrigendum to “Medical treatment of hypercortisolism with relacorilant: Final results of the phase 3 GRACE study” [American Heart Journal 278S (2024) Pages 10-11]
The authors regret that the information in the abstract that was published was incorrect. It should have the correct abstract information below. The authors would like to apologize for any…
read more

Effect of opt-in versus opt-out framing on trial recruitment: a study within a trial of the GAMEPAD randomized trial

Jun 27, 2026 by in CARDIOLOGY Comments Off on Effect of opt-in versus opt-out framing on trial recruitment: a study within a trial of the GAMEPAD randomized trial
ABSTRACT Directly contacting eligible participants with an offer to join a randomized clinical trial (RCT) is an efficient recruitment method, but the effect of different outreach strategies on enrollment fraction…
read more

Response to letter by Golestanieraghi regarding article, “Association between vasopressin administration and mortality in patients with cardiogenic shock”

Jun 27, 2026 by in CARDIOLOGY Comments Off on Response to letter by Golestanieraghi regarding article, “Association between vasopressin administration and mortality in patients with cardiogenic shock”
We greatly appreciate the thoughtful commentary by Dr. Dadashpour and Dr. Golestanieraghi on our article entitled “ Association between vasopressin administration and mortality in patients with cardiogenic shock .” We…
read more
Get Clinical Tree app for offline access